These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice. Sweeney FF; O'Leary OF; Cryan JF Neuropharmacology; 2014 Jun; 81():303-10. PubMed ID: 24050962 [TBL] [Abstract][Full Text] [Related]
4. Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology. Fendt M; Imobersteg S; Peterlik D; Chaperon F; Mattes C; Wittmann C; Olpe HR; Mosbacher J; Vranesic I; van der Putten H; McAllister KH; Flor PJ; Gee CE Neuropharmacology; 2013 Sep; 72():215-23. PubMed ID: 23664812 [TBL] [Abstract][Full Text] [Related]
5. A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats. Pałucha-Poniewiera A; Pilc A Behav Brain Res; 2013 Feb; 238():109-12. PubMed ID: 23085340 [TBL] [Abstract][Full Text] [Related]
6. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Palucha A; Klak K; Branski P; van der Putten H; Flor PJ; Pilc A Psychopharmacology (Berl); 2007 Nov; 194(4):555-62. PubMed ID: 17622518 [TBL] [Abstract][Full Text] [Related]
7. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Cryan JF; Kelly PH; Neijt HC; Sansig G; Flor PJ; van Der Putten H Eur J Neurosci; 2003 Jun; 17(11):2409-17. PubMed ID: 12814372 [TBL] [Abstract][Full Text] [Related]
8. Type-7 metabotropic glutamate receptors negatively regulate α Iacovelli L; Di Menna L; Peterlik D; Stangl C; Orlando R; Molinaro G; De Blasi A; Bruno V; Battaglia G; Flor PJ; Uschold-Schmidt N; Nicoletti F Neuropharmacology; 2017 Feb; 113(Pt A):343-353. PubMed ID: 27769854 [TBL] [Abstract][Full Text] [Related]
9. Relief from detrimental consequences of chronic psychosocial stress in mice deficient for the metabotropic glutamate receptor subtype 7. Peterlik D; Stangl C; Bludau A; Grabski D; Strasser R; Schmidt D; Flor PJ; Uschold-Schmidt N Neuropharmacology; 2017 Mar; 115():139-148. PubMed ID: 27188844 [TBL] [Abstract][Full Text] [Related]
10. Novel metabotropic glutamate receptor 4 and glutamate receptor 8 therapeutics for the treatment of anxiety. Raber J; Duvoisin RM Expert Opin Investig Drugs; 2015 Apr; 24(4):519-28. PubMed ID: 25518990 [TBL] [Abstract][Full Text] [Related]
11. Comparison of hippocampal metabotropic glutamate receptor 7 (mGlu7) mRNA levels in two animal models of depression. O'Mahony CM; Bravo JA; Dinan TG; Cryan JF Neurosci Lett; 2010 Sep; 482(2):137-41. PubMed ID: 20638442 [TBL] [Abstract][Full Text] [Related]
12. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus. Wierońska JM; Brański P; Siwek A; Dybala M; Nowak G; Pilc A Brain Res; 2010 Jun; 1334():12-24. PubMed ID: 20353761 [TBL] [Abstract][Full Text] [Related]
13. Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission. Stachowicz K; Brañski P; Kłak K; van der Putten H; Cryan JF; Flor PJ; Andrzej P Behav Pharmacol; 2008 Sep; 19(5-6):597-603. PubMed ID: 18690114 [TBL] [Abstract][Full Text] [Related]
15. Functional Dissociation of Group III Metabotropic Glutamate Receptors Revealed by Direct Comparison between the Behavioral Profiles of Knockout Mouse Lines. Goddyn H; Callaerts-Vegh Z; D'Hooge R Int J Neuropsychopharmacol; 2015 May; 18(11):pyv053. PubMed ID: 25999589 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]. Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514 [TBL] [Abstract][Full Text] [Related]